Financhill
Back

Equinix, Inc. Vs. Structure Therapeutics, Inc. Industry Stock Comparison

Sell
49

EQIX
Equinix, Inc.

Last Price:
$740.94
Seasonality Move:
-0.8%
Buy
67

GPCR
Structure Therapeutics, Inc.

Last Price:
$67.94
Seasonality Move:
-31.39%
Sell
49
Equinix, Inc. (EQIX) is a Sell

Is Equinix, Inc. a Buy, Sell or Hold?

  • The current Equinix, Inc. [EQIX] share price is $739.93. The Score for EQIX is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • EQIX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
67
Structure Therapeutics, Inc. (GPCR) is a Buy

Is Structure Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Structure Therapeutics, Inc. [GPCR] share price is $69.98. The Score for GPCR is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • GPCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

EQIX Stock Price Chart

What is Equinix, Inc.'s stock price today?

  • The Equinix, Inc. share price today is $739.93
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EQIX is experiencing selling pressure, which indicates risk of future bearish movement.

GPCR Stock Price Chart

What is Structure Therapeutics, Inc.'s stock price today?

  • The Structure Therapeutics, Inc. share price today is $69.98
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing slight buying pressure.

EQIX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -19.52 Sell
Relative Strength Index (14 RSI): 37.17 Sell
Chaikin Money Flow: -280498 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (739.78 - 812.66) Sell
Bollinger Bands (100): (762.59 - 813.99) Sell

GPCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.48 Buy
Relative Strength Index (14 RSI): 86.01 Buy
Chaikin Money Flow: 124529 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.63 - 42.89) Buy
Bollinger Bands (100): (18.11 - 33.75) Buy

EQIX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 738.09 Buy
20-day SMA: 763.83 Sell
50-day SMA: 792.83 Sell
200-day SMA: 815.53 Sell
8-day EMA: 740.81 Sell
20-day EMA: 759.77 Sell
50-day EMA: 780.86 Sell
200-day EMA: 812.07 Sell

GPCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.22 Buy
20-day SMA: 36.44 Buy
50-day SMA: 32.1 Buy
200-day SMA: 23.71 Buy
8-day EMA: 41.78 Buy
20-day EMA: 37.11 Buy
50-day EMA: 32.59 Buy
200-day EMA: 27.3 Buy

Equinix, Inc. Earnings Growth & EQIX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.81 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.64 per share, and an increase next year of $0.12 per share.

Structure Therapeutics, Inc. Earnings Growth & GPCR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.49 per share, and a decrease next year of $0.15 per share.

Equinix, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Structure Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):